Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide s.c. and LAR in Dumping Syndrome
NCT01637272Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2013
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of pasireotide LAR in dumping syndrome, sponsored by Novartis. Started Jan 2013; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
dumping syndrome
Beyond the preview
Go deeper on NCT01637272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637272.